Loading...
Improved glycemic control and reduced bodyweight with exenatide: A double‐blind, randomized, phase 3 study in Japanese patients with suboptimally controlled type 2 diabetes over 24 weeks
Aims/Introduction: To evaluate the efficacy and safety of the glucagon‐like peptide‐1 receptor agonist, exenatide, in Japanese patients with type 2 diabetes mellitus suboptimally controlled despite therapeutic doses of a sulfonylurea alone or combined with a biguanide or thiazolidinedione. Material...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Publishing Ltd
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4014921/ https://ncbi.nlm.nih.gov/pubmed/24843486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.2040-1124.2010.00084.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|